• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

表皮生长因子和三磷酸腺苷诱导乳腺癌细胞系中钠碘同向转运体的表达。

Epidermal Growth Factor and Adenosine Triphosphate Induce Natrium Iodide Symporter Expression in Breast Cancer Cell Lines.

作者信息

Elliyanti Aisyah, Putra Andani Eka, Sribudiani Yunia, Noormartany Noormartany, Masjhur Johan S, Achmad Tri Hanggono, Dachriyanus Dachriyanus

机构信息

Faculty of Medicine, Universitas Andalas, Padang, Indonesia.

出版信息

Open Access Maced J Med Sci. 2019 Jul 14;7(13):2088-2092. doi: 10.3889/oamjms.2019.620. eCollection 2019 Jul 15.

DOI:10.3889/oamjms.2019.620
PMID:31456831
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6698106/
Abstract

AIM

This study aims to investigate the effect of ATP, EGF and combination of those two to the Natrium Iodide Symporter (NIS) expression in MCF7, SKBR3 and HaCaT cell lines.

METHODS

MCF7, SKBR3 and HaCaT cell lines were treated with ATP, EGF and combination of those two for 6, 12 and 24 hours. The expression of NIS mRNA was measured through quantitative-reverse transcription-polymerase chain reaction (qRT-PCR). The NIS protein expression was confirmed by immunocytofluorescence.

RESULTS

NIS mRNA was expressed in SKBR3 and HaCaT cell lines but not in MCF7. The levels of NIS mRNA expression, after treatment by epidermal growth factor (EGF), adenosine Tri-Phosphate (ATP) or the combination of both for 6 and 12 hours were not significantly different from those of untreated cells. However, the treatment by a combination of ATP and EGF for 24 hours increases the level of NIS mRNA expression by 1.6 fold higher than that of the untreated cells (1.6241 ± 0.3, p < 0.05) and protein NIS expression increase significantly by the treatment than untreated cells (P < 0.05).

CONCLUSION

The level of NIS expression varies among the different subtypes of breast cancer cell lines. MCF7 cell line is representing the luminal A subtype of breast cancer does not express NIS. Only SKBR3 cell line express NIS and this subtype might be suitable to receive radioiodine therapy as those cells expressing NIS. A combination treatment of EGF and ATP increases the expression of NIS mRNA and protein at the membrane in SKBR3 cells.

摘要

目的

本研究旨在探讨三磷酸腺苷(ATP)、表皮生长因子(EGF)及其二者组合对MCF7、SKBR3和HaCaT细胞系中碘化钠转运体(NIS)表达的影响。

方法

用ATP、EGF及其二者组合处理MCF7、SKBR3和HaCaT细胞系6、12和24小时。通过定量逆转录聚合酶链反应(qRT-PCR)检测NIS mRNA的表达。通过免疫细胞荧光法确认NIS蛋白的表达。

结果

NIS mRNA在SKBR3和HaCaT细胞系中表达,但在MCF7中不表达。用表皮生长因子(EGF)、三磷酸腺苷(ATP)或二者组合处理6和12小时后,NIS mRNA表达水平与未处理细胞相比无显著差异。然而,ATP和EGF组合处理24小时使NIS mRNA表达水平比未处理细胞提高了1.6倍(1.6241±0.3,p<0.05),且处理后NIS蛋白表达比未处理细胞显著增加(P<0.05)。

结论

NIS表达水平在不同亚型的乳腺癌细胞系中有所不同。代表管腔A型乳腺癌的MCF7细胞系不表达NIS。只有SKBR3细胞系表达NIS,该亚型可能适合接受放射性碘治疗,因为这些细胞表达NIS。EGF和ATP联合处理可增加SKBR3细胞中NIS mRNA的表达及细胞膜上NIS蛋白的表达。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7d7/6698106/3eda67464332/OAMJMS-7-2088-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7d7/6698106/bde098853cb4/OAMJMS-7-2088-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7d7/6698106/69f3c3fc63b0/OAMJMS-7-2088-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7d7/6698106/3eda67464332/OAMJMS-7-2088-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7d7/6698106/bde098853cb4/OAMJMS-7-2088-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7d7/6698106/69f3c3fc63b0/OAMJMS-7-2088-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e7d7/6698106/3eda67464332/OAMJMS-7-2088-g003.jpg

相似文献

1
Epidermal Growth Factor and Adenosine Triphosphate Induce Natrium Iodide Symporter Expression in Breast Cancer Cell Lines.表皮生长因子和三磷酸腺苷诱导乳腺癌细胞系中钠碘同向转运体的表达。
Open Access Maced J Med Sci. 2019 Jul 14;7(13):2088-2092. doi: 10.3889/oamjms.2019.620. eCollection 2019 Jul 15.
2
Analysis Natrium Iodide Symporter Expression in Breast Cancer Subtypes for Radioiodine Therapy Response.分析乳腺癌亚型中碘化钠转运体表达与放射性碘治疗反应的关系。
Nucl Med Mol Imaging. 2020 Feb;54(1):35-42. doi: 10.1007/s13139-019-00632-8. Epub 2020 Jan 3.
3
Functional sodium iodide symporter expression in breast cancer xenografts in vivo after systemic treatment with retinoic acid and dexamethasone.经视黄酸和地塞米松全身治疗后,体内乳腺癌异种移植瘤中功能性碘化钠同向转运体的表达。
Breast Cancer Res Treat. 2008 May;109(2):263-72. doi: 10.1007/s10549-007-9646-0. Epub 2007 Jul 18.
4
Phosphoinositide-3-kinase inhibition induces sodium/iodide symporter expression in rat thyroid cells and human papillary thyroid cancer cells.磷脂酰肌醇-3-激酶抑制可诱导大鼠甲状腺细胞和人甲状腺乳头状癌细胞中钠/碘同向转运体的表达。
J Endocrinol. 2008 Nov;199(2):243-52. doi: 10.1677/JOE-08-0333. Epub 2008 Sep 1.
5
Hydrocortisone and purinergic signaling stimulate sodium/iodide symporter (NIS)-mediated iodide transport in breast cancer cells.氢化可的松和嘌呤能信号传导刺激乳腺癌细胞中钠/碘同向转运体(NIS)介导的碘转运。
Mol Endocrinol. 2006 May;20(5):1121-37. doi: 10.1210/me.2005-0376. Epub 2006 Jan 26.
6
Combined 2-deoxy glucose and metformin improves therapeutic efficacy of sodium-iodide symporter-mediated targeted radioiodine therapy in breast cancer cells.联合使用 2-脱氧葡萄糖和二甲双胍可提高钠-碘转运体介导的靶向放射性碘治疗乳腺癌细胞的疗效。
Breast Cancer (Dove Med Press). 2015 Aug 31;7:251-65. doi: 10.2147/BCTT.S84648. eCollection 2015.
7
Endogenous expression of the sodium iodide symporter mediates uptake of iodide in murine models of colorectal carcinoma.钠碘同向转运体的内源性表达介导了结直肠癌小鼠模型中碘化物的摄取。
Int J Cancer. 2009 Dec 15;125(12):2783-91. doi: 10.1002/ijc.24705.
8
Regulation and tissue distribution of the human sodium iodide symporter gene.人钠碘同向转运体基因的调控与组织分布
Clin Endocrinol (Oxf). 1998 Oct;49(4):517-23. doi: 10.1046/j.1365-2265.1998.00570.x.
9
Dexamethasone stimulation of retinoic Acid-induced sodium iodide symporter expression and cytotoxicity of 131-I in breast cancer cells.地塞米松对维甲酸诱导的乳腺癌细胞中碘化钠同向转运体表达及131-I细胞毒性的刺激作用
J Clin Endocrinol Metab. 2006 Jan;91(1):69-78. doi: 10.1210/jc.2005-0779. Epub 2005 Oct 18.
10
Stimulation of retinoic acid-induced functional sodium iodide symporter (NIS) expression and cytotoxicity of ¹³¹I by carbamazepine in breast cancer cells.卡马西平刺激视黄酸诱导的功能性钠碘同向转运体(NIS)表达和乳腺癌细胞中 ¹³¹I 的细胞毒性。
Breast Cancer Res Treat. 2011 Jan;125(2):377-86. doi: 10.1007/s10549-010-0835-x. Epub 2010 Mar 19.

引用本文的文献

1
Modulation of VEGF Expression and Oxidative Stress Response by Iodine Deficiency in Irradiated Cancerous and Non-Cancerous Breast Cells.碘缺乏对辐射致癌和非致癌乳腺细胞中血管内皮生长因子表达和氧化应激反应的调节。
Int J Mol Sci. 2020 May 31;21(11):3963. doi: 10.3390/ijms21113963.
2
Analysis Natrium Iodide Symporter Expression in Breast Cancer Subtypes for Radioiodine Therapy Response.分析乳腺癌亚型中碘化钠转运体表达与放射性碘治疗反应的关系。
Nucl Med Mol Imaging. 2020 Feb;54(1):35-42. doi: 10.1007/s13139-019-00632-8. Epub 2020 Jan 3.

本文引用的文献

1
The Sodium/Iodide Symporter (NIS): Molecular Physiology and Preclinical and Clinical Applications.钠/碘同向转运体(NIS):分子生理学及临床前和临床应用
Annu Rev Physiol. 2017 Feb 10;79:261-289. doi: 10.1146/annurev-physiol-022516-034125.
2
Expression of sodium iodide symporter in human breast tissues.碘化钠同向转运体在人乳腺组织中的表达。
J BUON. 2016 Jan-Feb;21(1):53-60.
3
Enhancement of human sodium iodide symporter gene therapy for breast cancer by HDAC inhibitor mediated transcriptional modulation.通过组蛋白去乙酰化酶抑制剂介导的转录调控增强人钠碘同向转运体基因治疗乳腺癌的效果
Sci Rep. 2016 Jan 18;6:19341. doi: 10.1038/srep19341.
4
Effect of sodium/iodide symporter (NIS)-mediated radioiodine therapy on estrogen receptor-negative breast cancer.钠/碘同向转运体(NIS)介导的放射性碘治疗对雌激素受体阴性乳腺癌的影响。
Oncol Rep. 2015 Jul;34(1):59-66. doi: 10.3892/or.2015.3946. Epub 2015 May 5.
5
Sodium iodide symporter (NIS) in extrathyroidal malignancies: focus on breast and urological cancer.甲状腺外恶性肿瘤中的碘化钠转运体(NIS):聚焦于乳腺癌和泌尿系统癌症。
BMC Cancer. 2014 Apr 30;14:303. doi: 10.1186/1471-2407-14-303.
6
Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.人表皮生长因子受体 2 检测在乳腺癌中的应用:美国临床肿瘤学会/美国病理学家学会临床实践指南更新。
J Clin Oncol. 2013 Nov 1;31(31):3997-4013. doi: 10.1200/JCO.2013.50.9984. Epub 2013 Oct 7.
7
The sodium/iodide symporter: state of the art of its molecular characterization.钠/碘同向转运体:其分子特征的最新进展
Biochim Biophys Acta. 2014 Jan;1838(1 Pt B):244-53. doi: 10.1016/j.bbamem.2013.08.013. Epub 2013 Aug 27.
8
False-positive uptake on radioiodine whole-body scintigraphy: physiologic and pathologic variants unrelated to thyroid cancer.放射性碘全身闪烁扫描中的假阳性摄取:与甲状腺癌无关的生理和病理变异
Am J Nucl Med Mol Imaging. 2012;2(3):362-85. Epub 2012 Jul 10.
9
Regulation of sodium iodide symporter gene expression by Rac1/p38β mitogen-activated protein kinase signaling pathway in MCF-7 breast cancer cells.Rac1/p38β 丝裂原活化蛋白激酶信号通路对 MCF-7 乳腺癌细胞钠碘同向转运体基因表达的调控。
J Biol Chem. 2012 Jan 27;287(5):3292-300. doi: 10.1074/jbc.M111.315523. Epub 2011 Dec 8.
10
Microarray analysis of genes associated with cell surface NIS protein levels in breast cancer.乳腺癌中与细胞表面NIS蛋白水平相关基因的微阵列分析。
BMC Res Notes. 2011 Oct 11;4:397. doi: 10.1186/1756-0500-4-397.